Official announcements
Replacement
|
Medicines
|
08/07/2014
The marketing authorization holder has informed wholesalers and pharmacies in a letter dated 07.07.2014 that the duration of the above batches was printed incorrectly and therefore a replacement will be made. The runtime indicated on the labeling is longer than the actual runtime: Batch 14701: Expiration date printed: 09/2016. Correct expiration…
Replacement
|
Medicines
|
03/07/2014
The marketing authorization holder informed its supplied customers by letter dated July 1, 2014, that the sedacoron batch DV6862 delivered in the period from February 2014 to May 2014 exhibited increased crystallization, so that a precautionary replacement will be carried out.
Recall
|
Medicines
|
18/06/2014
The marketing authorization holder informed its supplied customers in a letter dated 17.06.2014 that aflatoxin contamination resulting from contamination of individual batches of passionflower herb was detected due to subsequent, unscheduled special tests. Therefore, the two affected batches are recalled.
Recall
|
Medicines
|
17/06/2014
The marketing authorization holder informed its supplied customers in a letter dated June 16, 2014, that the manufacturer cannot rule out the possibility that the solution in individual bottles is contaminated with small black particles, so that a precautionary recall has been initiated.
Safety warnings
|
Medicines
|
04/06/2014
Update on stolen vials of Herceptin and other products, newly affected: Avastin and MabThera
Recall
|
Medicines
|
04/06/2014
The parallel distributor informed its supplied customers on 03.06.2014 and asked for a stock check of the affected batches.
Recall
|
Medicines
|
04/06/2014
The parallel distributor informed its supplied customers on 03.06.2014 and asked for a stock check of the affected batches.
Recall
|
Medicines
|
04/06/2014
The parallel distributor informed its supplied customers on 04.06.2014 and asked for a stock check of the affected batches.
Recall
|
Medicines
|
04/06/2014
The parallel distributor informed its supplied customers on June 4, 2014 and asked for a stock check of the affected batches.
Recall
|
Medicines
|
26/05/2014
In a letter dated May 26, 2014, the marketing authorization holder informed its customers that the degree of discoloration of batch 2G605A is just outside the permitted limit and the impurities are elevated. For batch 2M631A, although the degree of discoloration is within the allowed limit, the measured value for impurity B is 0.7%, which is above…